Tag: tetrahydrocannabinol

GW Pharma’s Epidiolex nears US launch

by Selina McKee | Sep 28, 2018 | News | 0

GW Pharmaceuticals and its subsidiary Greenwich Biosciences are gearing up to launch Epidiolex in the US after drug enforcement officials re-classified the cannabis-based medicine to the lowest restriction.

GW planing to test its cannabinoids in cancer

by Selina McKee | Feb 8, 2017 | News | 0

GW Pharma is strengthening its focus on oncology after promising mid-stage data for its cannabis-based therapy in patients with a rare and aggressive brain tumour called glioblastoma multiforme (GBM).